Seeing Is Believing

Currently out of the existing stock ratings of Steve Byrne, 108 are a HOLD (27.34%), 84 are a SELL (21.27%), 203 are a BUY (51.39%).
Analyst Steve Byrne, currently employed at BAML, carries an average stock price target met ratio of 58.33% that have a potential upside of 22.49% achieved within 266 days.
Steve Byrne’s has documented 760 price targets and ratings displayed on 46 stocks. The coverage is on Basic Materials, Consumer Defensive, Healthcare, Technology sectors.
Most recent stock forecast was given on CE, Celanese at 29-Jun-2026.
Analyst best performing recommendations are on INVA (INNOVIVA).
The best stock recommendation documented was for INVA (INNOVIVA) at 2/19/2015. The price target of $17 was fulfilled within 1 day with a profit of $0.68 (4.17%) receiving and performance score of 41.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 03-Jan-2024
$130
$24.97 (23.77%)
$185
Hold Since 27-Feb-2023
$140
$34.97 (33.30%)
1 months 7 days ago
(24-Aug-2026)
6/8 (75%)
$7.27 (5.48%)
10
Buy Since 13-May-2026
$190
$84.97 (80.90%)
$200
1 months 22 days ago
(09-Aug-2026)
5/10 (50%)
$59.23 (45.29%)
310
Buy Since 09-May-2022
$157
$51.97 (49.48%)
$257
1 months 22 days ago
(09-Aug-2026)
34/47 (72.34%)
$26.23 (20.06%)
467
Buy Since 25-Mar-2026
$225
$119.97 (114.22%)
$245
1 months 25 days ago
(06-Aug-2026)
7/15 (46.67%)
$94.33 (72.19%)
123
Which stock is Steve Byrne most bullish on?
Which stock is Steve Byrne most reserved on?
What Year was the first public recommendation made by Steve Byrne?